Fennec Pharmaceuticals Inc. Common Stock (FENC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Headquarters
- United States
- Employees
- 35
- Market Cap
- $386M
About Fennec Pharmaceuticals Inc. Common Stock
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
SentiSense also tracks daily options readings for Fennec Pharmaceuticals Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Fennec Pharmaceuticals Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.